Northwest Biotherapeutics | NWBO - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Northwest Biotherapeutics

Northwest Biotherapeutics reported $44.71M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
AstraZeneca AZN:LN USD 24.86B 1.43B
Celldex Therapeutics CLDX:US USD 15.22M 3.39M
CTI Biopharma CTIC:US USD 68.23M 12.91M
Eisai 4523:JP JPY 298.94B 14.73B
Infinity Pharmaceuticals INFI:US USD 11.29M 2.34M
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Northwest Biotherapeutics NWBO:US USD 44.71M 81.3M
Plus Therapeutics, Inc. CYTX:US USD 12.8M 944K
Roche Holding ROG:VX CHF 27.24B 170M